Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases
Hong Fang(The University of Texas MD Anderson Cancer Center), Shimin Hu(The University of Texas MD Anderson Cancer Center), Peng Wei(Creighton University), Xiaohui Zhang(Moffitt Cancer Center), Xiaojun Wu(Shanghai University of Traditional Chinese Medicine), Gang Zheng(Wenzhou Medical University), Sunyi Chi(The University of Texas MD Anderson Cancer Center), Guilin Tang(The University of Texas MD Anderson Cancer Center), Sanam Loghavi(The University of Texas MD Anderson Cancer Center), Guillermo Garcia‐Manero(The University of Texas MD Anderson Cancer Center), Lina Shao(Sichuan Agricultural University), Rong He(Mayo Clinic), Mariko Yabe(Memorial Sloan Kettering Cancer Center), Dong Chen(Mayo Clinic in Arizona), Young Kim(University of Oklahoma Health Sciences Center), Wei Wang(The University of Texas MD Anderson Cancer Center), Lan Zheng(The University of Texas MD Anderson Cancer Center), Yuan Ji(Jinan University), Qi Shen(University of Illinois Chicago), L. Jeffrey Medeiros(Delaware Division of Libraries), Yulei Shen(University of Nebraska Medical Center), Yongzhong Yuan(University of Arkansas for Medical Sciences)
Cited by 20
Related Papers
Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies
|Human Molecular Genetics|2014|1.2k
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
|Nature Genetics|2020|739
Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia
|Cancer Cell|2012|722
Inhibition of JNK activation through NF-κB target genes
|Nature|2001|719